COVID-19 remains a public health threat.¹

As a healthcare provider, you play a vital role in protecting your patients and their health. Learn more about how to educate them on their risk for hospitalization or death from COVID-19.

Get resources

5 things to know about COVID-19

1.

COVID-19 is more serious than the flu.

Between October 2023 and July 2024, COVID-19 hospitalization rates were 90.5% higher than flu.²

2.

COVID-19 vaccine uptake remains lower than the flu.

COVID-19 vaccination rates among adults remain lower than those of influenza, despite similar risks of severe outcomes.3,4

3.

Unvaccinated COVID-19 patients are at a higher risk for death.

A 2023 study found that among patients with a COVID-19 infection, those who remained unvaccinated were ~2.5x more likely to die, compared to those who were vaccinated.⁵

4.

The CDC has issued a new recommendation.

On June 27, 2024, continuing its guidance from the previous year, the CDC again recommended an updated COVID-19 vaccine for eligible individuals ages 6 months and older.⁶

5.

Long COVID can impact anyone.

Older adults and those with comorbidities have a higher risk of severe outcomes from a COVID-19 infection.¹ However, anyone that gets COVID-19 is at risk of having Long COVID - not just those with severe illness.⁷

COVID-19 hospitalization rates were
90.5%
higher than the flu during the 2023-2024 season.²
Unvaccinated patients have a
~2.5x
higher risk of death.⁵
Use this timeline as a reference to determine when to recommend the updated vaccine for otherwise healthy patients who had summer infections.

Post-infection guidance: When to recommend the updated COVID-19 vaccine

In the summer of 2024, the US experienced another summer “surge” in COVID-19 cases, with roughly 15,000 Americans hospitalized with COVID-19 at its peak.11*

Patients who had COVID this summer may be wondering how their immunity is holding up and whether–or when–they need to get the 2024-2025 updated COVID-19 vaccine. 

According to the CDC, most patients who have recently recovered from COVID-19, whether symptomatic or asymptomatic, may consider receiving their updated COVID-19 vaccination within 3 months after an infection.¹² For guidance on immunocompromised patients, see the CDC guidelines.

Get the HCP guide
Ready to vaccinate?
View our digital library of tools to help enhance your vaccination efforts.
See our resources

2024-2025 ACIP Vaccination Recommendation – Updated October 2024

In addition to previously recommended 2024-2025 vaccination guidelines,* the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend the following 2024-2025 COVID-19 vaccine updates:13, 14

  • A second dose of 2024-2025 COVID-19 for adults ages 65 years and older.
  • A second dose of 2024-2025 COVID-19 vaccine for people ages 6 months-64 years who are moderately or severely immunocompromised.
  • Additional doses (i.e., 3 or more doses) of 2024-2025 COVID-19 vaccine for people ages 6 months and older who are moderately or severely immunocompromised under shared clinical decision making.

*On June 27, 2024, the ACIP recommended 2024–2025 COVID-19 vaccination with an FDA–authorized or approved vaccine for all persons aged ≥6 months to target currently circulating SARS-CoV-2 strains and provide additional protection against severe COVID-19–associated illness and death.14


Evolution of COVID-19

The SARS-CoV-2 virus (which causes COVID-19) continues to evolve, resulting in new variants and lineages.⁸

As a result, vaccine formulations need to be adjusted periodically in an effort to keep pace with the evolving virus.⁹

On June 13th, 2024, the FDA updated its recommendation asking vaccine manufacturers to use a lineage of JN.1 called the KP.2 strain.¹⁰

Learn more about variants, lineages, and sublineages

Where to order vaccines

Stay prepared with the latest COVID-19 vaccines. Access ordering options tailored to meet your specific needs.

Find an Authorized Distributor
How to order on ModernaDirect.com

Learn more about how COVID-19 can impact your patients


* The highest weekly rate of COVID-19 hospitalization was recorded by the CDC the week of 8/10/24.
11. Centers for Disease Control, “COVID-NET Laboratory-confirmed COVID-19 hospitalizations.” Accessed October 3, 2024.https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network

References

  1. Centers for Disease Control, “The Changing Threat of COVID-19.” Updated February 23, 2024. Accessed July 31, 2024. https://www.cdc.gov/ncird/whats-new/changing-threat-covid-19.html
  2. Centers for Disease Control, “Respiratory Virus Hospitalization Surveillance Network (RESP-NET).” Updated August 16, 2024. Accessed August 20, 2024. https://www.cdc.gov/resp-net/dashboard/
  3. Centers for Disease Control, “Vaccination Trends.” Updated October 18, 2024. Accessed October 22, 2024. https://www.cdc.gov/respiratory-viruses/data/vaccination-trends.html
  4. Centers for Disease Control, “Study Shows Hospital Outcomes for Flu and COVID-19 Have Become More Similar.” Updated January 24, 2024. Accessed October 22, 2024.https://www.cdc.gov/flu/whats-new/2023-2024-hospital-outcomes.html
  5. Ikeokwu A. et al., "Unveiling the Impact of COVID-19 Vaccines: A Meta-Analysis of Survival Rates Among Patients in the United States Based on Vaccination Status," Cureus, Vol. 15(8), 2023.https://www.cureus.com/articles/163598-unveiling-the-impact-of-covid-19-vaccines-a-meta-analysis-of-survival-rates-among-patients-in-the-united-states-based-on-vaccination-status
  6. Centers for Disease Control, “CDC Recommends Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season.” Updated June 27, 2024. Accessed July 31, 2024. https://www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html
  7. Centers for Disease Control, “CDC Science and the Public Health Approach to Long COVID.” Updated July 12, 2024. Accessed August 6, 2024. https://www.cdc.gov/covid/php/long-covid/index.html
  8. Centers for Disease Control, “Variants Happen." Updated October 27. 2023. Accessed August 9, 2024. https://www.cdc.gov/ncird/whats-new/variants-happen.html
  9. World Health Organization, “The Effects of Virus Variants on COVID-19 Vaccines.” Updated March 1, 2021. Accessed June 5, 2024. https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines
  10. US Food & Drug Administration, “Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2024.” Updated June 13, 2024. Accessed June 20, 2024. https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2024
  11. Centers for Disease Control, “COVID-NET Laboratory-confirmed COVID-19 hospitalizations.” Accessed October 3, 2024.https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network
  12. Centers for Disease Control, “Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States.” Updated September 6, 2024. Accessed October 3, 2024.https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
  13. Panagiotakopoulos L. et al., “Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025,” Morbidity and Mortality Weekly Report (MMWR), Vol 73(37), 2024.https://www.cdc.gov/mmwr/volumes/73/wr/mm7337e2.htm
  14. Centers for Disease Control, “CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised.” Updated October 23, 2024. Accessed October 23, 2024.https://www.cdc.gov/media/releases/2024/s1023-covid-19-vaccine.html
Terms and conditionsPrivacy statement

© 2024 Moderna US-COV-2400039 08/2024